Show simple item record

A randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3

dc.contributor.authorFoster, GRen_US
dc.contributor.authorChayama, Ken_US
dc.contributor.authorChuang, W-Len_US
dc.contributor.authorFainboim, Hen_US
dc.contributor.authorFarkkila, Men_US
dc.contributor.authorGadano, Aen_US
dc.contributor.authorGaeta, GBen_US
dc.contributor.authorHezode, Cen_US
dc.contributor.authorInada, Yen_US
dc.contributor.authorHeo, Jen_US
dc.contributor.authorKumada, Hen_US
dc.contributor.authorLu, S-Nen_US
dc.contributor.authorMarcellin, Pen_US
dc.contributor.authorMoreno, Cen_US
dc.contributor.authorRoberts, SKen_US
dc.contributor.authorStrasser, SIen_US
dc.contributor.authorThompson, AJen_US
dc.contributor.authorToyota, Jen_US
dc.contributor.authorPaik, SWen_US
dc.contributor.authorVierling, JMen_US
dc.contributor.authorZignego, ALen_US
dc.contributor.authorCohen, Den_US
dc.contributor.authorMcPhee, Fen_US
dc.contributor.authorWind-Rotolo, Men_US
dc.contributor.authorSrinivasan, Sen_US
dc.contributor.authorHruska, Men_US
dc.contributor.authorMyler, Hen_US
dc.contributor.authorPortsmouth, SDen_US
dc.date.accessioned2016-10-03T15:04:26Z
dc.date.available2016-07-27en_US
dc.date.issued2016-08-19en_US
dc.date.submitted2016-09-27T12:52:17.561Z
dc.identifier.issn2193-1801en_US
dc.identifier.otherARTN 1365en_US
dc.identifier.otherARTN 1365en_US
dc.identifier.otherARTN 1365en_US
dc.identifier.otherARTN 1365en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/15696
dc.description.sponsorshipThis study was funded by Bristol-Myers Squibb.en_US
dc.relation.ispartofSPRINGERPLUSen_US
dc.rightsThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
dc.subjectHepatitis C virusen_US
dc.subjectGenotype 2en_US
dc.subjectGenotype 3en_US
dc.subjectPeginterferon lambda-1aen_US
dc.subjectPeginterferon alfa-2aen_US
dc.titleA randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3en_US
dc.typeArticle
dc.identifier.doi10.1186/s40064-016-2920-zen_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000381644200001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume5en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record